Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300–2306

Autor:	Steven A. Smith, Andrew D. Calvin, Victor M. Montori, Niti R. Aggarwal, Qian Shi, Julianna F. Lampropulos, M. Mercè Fernández-Balsells, Jeffrey B. Geske, Patricia J. Erwin, Mohammad Hassan Murad, Felipe N. Albuquerque, Mohamed B. Elamin
Rok vydání:	2018
Předmět:	Advanced and Specialized Nursing medicine.medical_specialty Aspirin business.industry Endocrinology Diabetes and Metabolism MEDLINE Diabetes status 030209 endocrinology & metabolism medicine.disease 03 medical and health sciences 0302 clinical medicine Meta-analysis Internal medicine Relative risk Diabetes mellitus Primary prevention Internal Medicine Medicine 030212 general & internal medicine Myocardial infarction business medicine.drug
Zdroj:	Diabetes Care. 41:1321.2-1322
ISSN:	1935-5548 0149-5992
Popis:	In the article cited above, Fig. 2 should have shown the pooled relative risks and 95% CI for the effect of aspirin versus control on death, myocardial infarction, and ischemic stroke, respectively, stratified by diabetes status of the trial participants. The published version of the manuscript incorrectly labeled the …
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9547450ba456b818e00cb9cffea3e962 https://doi.org/10.2337/dc18-er06a Zobrazit plný text záznamu